The focus of our research is mainly directed towards elucidating any possible overlapping signaling pathways that may be activated by these two lipids in the human neuroblastoma SH-SY5Y cell line when present simultaneously with IFNβ in a pharmacological combination, thereby suggesting a possible contributing role of OEA and PEA in the development of alternative therapeutic strategies. This evidence concerns the gene IFNB1 and neuroblastoma.